Literature DB >> 28986419

Type III interferon is a critical regulator of innate antifungal immunity.

Vanessa Espinosa1, Orchi Dutta1,2, Constance McElrath1,2,3, Peicheng Du4,5, Yun-Juan Chang4,5, Bryan Cicciarelli3, Amy Pitler3, Ian Whitehead3, Joshua J Obar6, Joan E Durbin1,7, Sergei V Kotenko1,3, Amariliz Rivera8,9.   

Abstract

Type III interferons (IFN-λs) are the most recently found members of the IFN cytokine family and engage IFNLR1 and IL10R2 receptor subunits to activate innate responses against viruses. We have identified IFN-λs as critical instructors of antifungal neutrophil responses. Using Aspergillus fumigatus (Af) as a model to study antifungal immune responses, we found that depletion of CCR2+ monocytes compromised the ability of neutrophils to control invasive fungal growth. Using an unbiased approach, we identified type I and III IFNs as critical regulators of the interplay between monocytes and neutrophils responding to Af We found that CCR2+ monocytes are an important early source of type I IFNs that prime optimal expression of IFN-λ. Type III IFNs act directly on neutrophils to activate their antifungal response, and mice with neutrophil-specific deletion of IFNLR1 succumb to invasive aspergillosis. Dysfunctional neutrophil responses in CCR2-depleted mice were rescued by adoptive transfer of pulmonary CCR2+ monocytes or by exogenous administration of IFN-α and IFN-λ. Thus, CCR2+ monocytes promote optimal activation of antifungal neutrophils by initiating a coordinated IFN response. We have identified type III IFNs as critical regulators of neutrophil activation and type I IFNs as early stimulators of IFN-λ expression.
Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28986419      PMCID: PMC5880030          DOI: 10.1126/sciimmunol.aan5357

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  40 in total

1.  IL-28, IL-29 and their class II cytokine receptor IL-28R.

Authors:  Paul Sheppard; Wayne Kindsvogel; Wenfeng Xu; Katherine Henderson; Stacy Schlutsmeyer; Theodore E Whitmore; Rolf Kuestner; Ursula Garrigues; Carl Birks; Jenny Roraback; Craig Ostrander; Dennis Dong; Jinu Shin; Scott Presnell; Brian Fox; Betty Haldeman; Emily Cooper; David Taft; Teresa Gilbert; Francis J Grant; Monica Tackett; William Krivan; Gary McKnight; Chris Clegg; Don Foster; Kevin M Klucher
Journal:  Nat Immunol       Date:  2002-12-02       Impact factor: 25.606

Review 2.  Contribution of type III interferons to antiviral immunity: location, location, location.

Authors:  Sergei V Kotenko; Joan E Durbin
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

3.  Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity.

Authors:  Timothy J Nice; Megan T Baldridge; Broc T McCune; Jason M Norman; Helen M Lazear; Maxim Artyomov; Michael S Diamond; Herbert W Virgin
Journal:  Science       Date:  2014-11-27       Impact factor: 47.728

Review 4.  Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management.

Authors:  E Liana Falcone; Steven M Holland
Journal:  Curr Opin Infect Dis       Date:  2012-12       Impact factor: 4.915

5.  Chronic granulomatous disease in adults.

Authors:  J G Liese; V Jendrossek; A Jansson; T Petropoulou; S Kloos; M Gahr; B H Belohradsky
Journal:  Lancet       Date:  1996-01-27       Impact factor: 79.321

Review 6.  The Roles of Type I Interferon in Bacterial Infection.

Authors:  Gayle M Boxx; Genhong Cheng
Journal:  Cell Host Microbe       Date:  2016-06-08       Impact factor: 21.023

Review 7.  Interferon induction and function at the mucosal surface.

Authors:  Russell K Durbin; Sergei V Kotenko; Joan E Durbin
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

8.  IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production.

Authors:  Katrina Blazek; Hayley L Eames; Miriam Weiss; Adam J Byrne; Dany Perocheau; James E Pease; Sean Doyle; Fiona McCann; Richard O Williams; Irina A Udalova
Journal:  J Exp Med       Date:  2015-05-04       Impact factor: 14.307

9.  Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia.

Authors:  Stefania Crotta; Sophia Davidson; Tanel Mahlakoiv; Christophe J Desmet; Matthew R Buckwalter; Matthew L Albert; Peter Staeheli; Andreas Wack
Journal:  PLoS Pathog       Date:  2013-11-21       Impact factor: 6.823

10.  IL-1α signaling is critical for leukocyte recruitment after pulmonary Aspergillus fumigatus challenge.

Authors:  Alayna K Caffrey; Margaret M Lehmann; Julianne M Zickovich; Vanessa Espinosa; Kelly M Shepardson; Christopher P Watschke; Kimberly M Hilmer; Arsa Thammahong; Bridget M Barker; Amariliz Rivera; Robert A Cramer; Joshua J Obar
Journal:  PLoS Pathog       Date:  2015-01-28       Impact factor: 6.823

View more
  80 in total

1.  Influenza Suppresses Neutrophil Recruitment to the Lung and Exacerbates Secondary Invasive Pulmonary Aspergillosis.

Authors:  Joshua M Tobin; Kara L Nickolich; Krishnaveni Ramanan; Matthew J Pilewski; Kristina D Lamens; John F Alcorn; Keven M Robinson
Journal:  J Immunol       Date:  2020-06-10       Impact factor: 5.422

2.  Meeting Overview: Interferon Lambda-Disease Impact and Therapeutic Potential.

Authors:  Thomas R O'Brien; Howard A Young; Raymond P Donnelly; Ludmila Prokunina-Olsson
Journal:  J Interferon Cytokine Res       Date:  2019-04-17       Impact factor: 2.607

Review 3.  Interferon Lambda's New Role as Regulator of Neutrophil Function.

Authors:  Amariliz Rivera
Journal:  J Interferon Cytokine Res       Date:  2019-04-23       Impact factor: 2.607

Review 4.  Type III IFNs: Beyond antiviral protection.

Authors:  Sergei V Kotenko; Amariliz Rivera; Dane Parker; Joan E Durbin
Journal:  Semin Immunol       Date:  2019-06       Impact factor: 11.130

Review 5.  Host defense mechanisms against Aspergillus fumigatus lung colonization and invasion.

Authors:  Joseph J Mackel; Chad Steele
Journal:  Curr Opin Microbiol       Date:  2019-05-16       Impact factor: 7.934

Review 6.  The first line of defense: effector pathways of anti-fungal innate immunity.

Authors:  Rebecca A Ward; Jatin M Vyas
Journal:  Curr Opin Microbiol       Date:  2020-11-17       Impact factor: 7.934

7.  Reply to Bazaz and Denning.

Authors:  Georgios Chamilos; Michail S Lionakis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2018-06-18       Impact factor: 9.079

Review 8.  Antifungal Innate Immunity: A Perspective from the Last 10 Years.

Authors:  Fabián Salazar; Gordon D Brown
Journal:  J Innate Immun       Date:  2018-05-16       Impact factor: 7.349

9.  Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus.

Authors:  Rishi R Goel; Xinghao Wang; Liam J O'Neil; Shuichiro Nakabo; Kowser Hasneen; Sarthak Gupta; Gustaf Wigerblad; Luz P Blanco; Jeffrey B Kopp; Maria I Morasso; Sergei V Kotenko; Zu-Xi Yu; Carmelo Carmona-Rivera; Mariana J Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-24       Impact factor: 11.205

10.  MDA5 Is an Essential Sensor of a Pathogen-Associated Molecular Pattern Associated with Vitality That Is Necessary for Host Resistance against Aspergillus fumigatus.

Authors:  Xi Wang; Alayna K Caffrey-Carr; Ko-Wei Liu; Vanessa Espinosa; Walburga Croteau; Sourabh Dhingra; Amariliz Rivera; Robert A Cramer; Joshua J Obar
Journal:  J Immunol       Date:  2020-10-21       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.